Candriam S.C.A. Illumina, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Illumina, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 138,270 shares of ILMN stock, worth $20 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

138,270

Previous 205,043 32.57%

Holding current value

$20 Million

Previous $21.4 Million 15.76%

% of portfolio

0.11%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$105.28 - $135.9 $7.03 Million - $9.07 Million	-66,773 Reduced 32.57%	138,270 $18 Million
Q2 2024 Aug 05, 2024	BUY	$101.05 - $133.57 $1.65 Million - $2.17 Million	16,283 Added 8.63%	205,043 $21.4 Million
Q1 2024 May 03, 2024	BUY	$127.73 - $147.2 $188,912 - $217,708	1,479 Added 0.79%	188,760 $25.9 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $2.8 Million - $4.3 Million	30,163 Added 19.2%	187,281 $26.1 Million
Q3 2023 Nov 13, 2023	SELL	$128.91 - $192.44 $2.84 Million - $4.24 Million	-22,015 Reduced 12.29%	157,118 $21.6 Million
Q2 2023 Aug 08, 2023	SELL	$183.43 - $232.67 $2.9 Million - $3.68 Million	-15,805 Reduced 8.11%	179,133 $33.6 Million
Q1 2023 May 12, 2023	SELL	$193.75 - $232.55 $9.07 Million - $10.9 Million	-46,820 Reduced 19.37%	194,938 $45.3 Million
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $525,208 - $680,885	-2,805 Reduced 1.15%	241,758 $48.9 Million
Q3 2022 Nov 10, 2022	BUY	$177.23 - $227.44 $3.22 Million - $4.14 Million	18,194 Added 8.04%	244,563 $46.7 Million
Q2 2022 Aug 03, 2022	SELL	$181.58 - $368.0 $454,676 - $921,472	-2,504 Reduced 1.09%	226,369 $41.7 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $3.55 Million - $4.95 Million	-11,676 Reduced 4.85%	228,873 $80 Million
Q4 2021 Feb 10, 2022	BUY	$347.28 - $421.83 $5.87 Million - $7.13 Million	16,902 Added 7.56%	240,549 $91.5 Million
Q3 2021 Nov 09, 2021	BUY	$405.61 - $524.84 $11.1 Million - $14.4 Million	27,362 Added 13.94%	223,647 $90.7 Million
Q2 2021 Jul 20, 2021	SELL	$372.84 - $481.5 $15.1 Million - $19.5 Million	-40,549 Reduced 17.12%	196,285 $92.9 Million
Q1 2021 Apr 29, 2021	SELL	$361.28 - $504.76 $722 - $1,009	-2 Reduced -0.0%	236,834 $84.2 Million
Q4 2020 Jan 22, 2021	SELL	$292.7 - $370.96 $17.8 Million - $22.5 Million	-60,746 Reduced 20.41%	236,836 $87.6 Million
Q3 2020 Oct 19, 2020	BUY	$268.51 - $400.74 $30.6 Million - $45.7 Million	114,044 Added 62.14%	297,582 $92 Million
Q2 2020 Jul 23, 2020	SELL	$256.46 - $373.01 $10.1 Million - $14.7 Million	-39,499 Reduced 17.71%	183,538 $68 Million
Q1 2020 May 26, 2020	BUY	$209.2 - $335.53 $1,255 - $2,013	6 Added 0.0%	223,037 $72.3 Million
Q4 2019 Jan 21, 2020	SELL	$288.29 - $335.49 $11.2 Million - $13.1 Million	-39,013 Reduced 14.89%	223,031 $74,000
Q3 2019 Oct 21, 2019	BUY	$266.84 - $378.23 $3.35 Million - $4.75 Million	12,562 Added 5.04%	262,044 $80,000
Q2 2019 Aug 01, 2019	BUY	$300.59 - $368.15 $5.73 Million - $7.02 Million	19,072 Added 8.28%	249,482 $91.4 Million
Q1 2019 May 02, 2019	SELL	$272.57 - $321.18 $190,799 - $224,826	-700 Reduced 0.3%	230,410 $71.6 Million
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $12.6 Million - $16.9 Million	46,155 Added 24.95%	231,110 $69.3 Million
Q3 2018 Nov 07, 2018	BUY	$279.04 - $367.06 $22.1 Million - $29.1 Million	79,323 Added 75.09%	184,955 $67.9 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $1.99 Million - $2.54 Million	8,700 Added 8.98%	105,632 $29.5 Million
Q1 2018 May 09, 2018	BUY	$209.54 - $253.91 $682,052 - $826,477	3,255 Added 3.47%	96,932 $22.9 Million
Q4 2017 Feb 07, 2018	SELL	$202.23 - $230.03 $3.37 Million - $3.83 Million	-16,670 Reduced 15.11%	93,677 $20.5 Million
Q3 2017 Nov 03, 2017	BUY	$172.3 - $213.93 $19 Million - $23.6 Million	110,347	110,347 $22 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account